Drug Trial Radar · NCT06897475
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Last checked: Nov 19, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
200
Planned (sponsor's estimate)
Start
Mar 28, 2025
Primary completion
May 2027
Study completion Jun 2027
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Mar 27, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to measure the change in hemoglobin A1c (HbA1c) with LY3457263 compared with placebo in participants with type 2 diabetes who are not at HbA1c goal when treated with a stable dose of semaglutide or tirzepatide. Participation in the study will last about 9 months.
Conditions
- Type 2 Diabetes
Interventions
LY3457263Drug
Administered SC
PlaceboDrug
Administered SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline in Hemoglobin A1c (HbA1c)Time frame: Baseline, Week 24
Locations
60 sites in 6 countries. Site status is shown where the registry gives one.
Helios Clinical Research - Phoenix
Phoenix, Arizona · Recruiting
Wolverine Clinical Trials
Santa Ana, California · Recruiting
Renstar Medical Research
Ocala, Florida · Recruiting
Oviedo Medical Research
Oviedo, Florida · Recruiting
Balanced Life Health Care Solutions/SKYCRNG
Lawrenceville, Georgia · Recruiting
Physicians Research Associates
Lawrenceville, Georgia · Recruiting
Rophe Adult and Pediatric Medicine/SKYCRNG
Union City, Georgia · Recruiting
North Georgia Clinical Research
Woodstock, Georgia · Recruiting
Elite Clinical Trials
Rexburg, Idaho · Recruiting
Investigators Research Group
Brownsburg, Indiana · Recruiting
Clinical Research of Philadelphia
Pennington, New Jersey · Recruiting
NYC Research INC
Long Island City, New York · Recruiting
Richmond University Medical Center
Staten Island, New York · Recruiting
Southgate Medical Group
West Seneca, New York · Recruiting
Lucas Research, Inc.
Morehead City, North Carolina · Recruiting
Shelby Clinical Research
Shelby, North Carolina · Recruiting
Providence Health Partners-Center for Clinical Research
Dayton, Ohio · Recruiting
Alliance for Multispecialty Research, LLC
Norman, Oklahoma · Recruiting
Frontier Clinical Research, LLC
Scottdale, Pennsylvania · Recruiting
Juno Research
Houston, Texas · Recruiting
Southern Endocrinology Associates
Mesquite, Texas · Recruiting
Texas Diabetes & Endocrinology, P.A.
Round Rock, Texas · Recruiting
Consano Clinical Research, LLC
Shavano Park, Texas · Recruiting
Texas Valley Clinical Research
Weslaco, Texas · Recruiting
Eastside Research Associates
Redmond, Washington · Recruiting
Centricity Research Brampton Endocrinology
Brampton, Canada · Recruiting
Ecogene-21
Chicoutimi, Canada · Recruiting
Winterberry Research Inc.
Hamilton, Canada · Recruiting
Viacar Recherche Clinique
Longueuil, Canada · Recruiting
G A Research Associates
Moncton, Canada · Recruiting
Bluewater Clinical Research Group Inc.
Sarnia, Canada · Recruiting
Maple Leaf Research
Toronto, Canada · Recruiting
Diabetes Heart Research Centre
Toronto, Canada · Recruiting
Fadia El Boreky Medicine
Waterloo, Canada · Recruiting
InnoDiab Forschung Gmbh
Essen, Germany · Completed
Velocity Clinical Research, Leipzig
Leipzig, Germany · Active not recruiting
Gemeinschaftspraxis Dr. Taeschner/Dr. Bonigut
Leipzig, Germany · Completed
Institut für Diabetesforschung GmbH Münster
Münster, Germany · Active not recruiting
RED-Institut GmbH
Oldenburg, Germany · Active not recruiting
Legeartis - Poradnie Specjalistyczne
Bialystok, Poland · Recruiting
Showing 40 of 60 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.